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Abstract
Matrilin-2 (Matn2) is a multidomain adaptor protein which plays a role in the assembly of extracellular matrix (ECM). It is
produced by oval cells during stem cell-driven liver regeneration. In our study, the impact of Matn2 on
hepatocarcinogenesis was investigated in Matn2-/- mice comparing them with wild-type (WT) mice in a diethylnitrosamine
(DEN) model. The liver tissue was analyzed macroscopically, histologically and immunohistochemically, at protein level by
Proteome Profiler Arrays and Western blot analysis. Matn2-/- mice exhibited higher susceptibility to hepatocarcinogenesis
compared to wild-type mice. In the liver of Matn2-/- mice, spontaneous microscopic tumor foci were detected without DEN
treatment. After 15 mg/g body weight DEN treatment, the liver of Matn2-/- mice contained macroscopic tumors of both
larger number and size than the WT liver. In contrast with the WT liver, spontaneous phosphorylation of EGFR, Erk1/2 GSK-
3a/b and retinoblastoma protein (p-Rb), decrease in p21/CIP1 level, and increase in b-Catenin protein expression were
detected in Matn2-/- livers. Focal Ki-67 positivity of these samples provided additional support to our presumption that the
lack of Matn2 drives the liver into a pro-proliferatory state, making it prone to tumor development. This enhanced
proliferative capacity was further increased in the tumor nodules of DEN-treated Matn2-/- livers. Our study suggests that
Matn2 functions as a tumor suppressor in hepatocarcinogenesis, and in this process activation of EGFR together with that of
Erk1/2, as well as inactivation of GSK-3b, play strategic roles.
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Introduction
Matrilins are non-collagenous glycoproteins implicated in the
organization of extracellular matrix (ECM) [1]. They can form
homo-oligomers and assemble into filamentous networks, which
are either connected to or independent of collagen fibrils. As
matrilins can interact via their von Willebrand factor type A
(vWFA) domains with various ECM components including
proteoglycans and collagens, they are proposed to fulfill a bridging
function in the ECM assembly of various tissues [2]. The matrilin
family consists of four members (matrilin-1, -2, -3, -4). Matrilin-2
(Matn2) is the largest member with a minimum Mr of 104300 of
the secreted monomer [3]. It is encoded by a gene spanning over
100 kb and transcribed from two promoters [4]. The Matn2
monomer is composed of two von Willebrand factor A-like
domains, 10 epidermal growth factor-like modules, one unique
sequence, and one coiled-coil domain [3]. Via the coiled-coil
domain, Matn2 assembles into oligomers and can be detected as a
mixture of monomers, dimers, trimers, and tetramers in tissue
extracts and in the medium of cultured cells [5]. Matn2 can bind
to fibrillar collagens, fibronectin and laminin-nidogen-1 complex
[6]. Mann et al. found that integrin a1b1 does not play a major
role in cellular interactions with matrilins. In the case of Matn2 a
weak binding signal with soluble integrin a1b1 was seen, while the
integrin a2b1 ectodomains did not show any binding [7].
However, the interaction between matrilins and integrins is
comparatively weak, matrilins promote only weak cell attachment,
and fail to trigger the formation of focal adhesions. It is not clear
whether this weak interaction with integrins can activate signal
transduction and induce gene expression [7,8].
The matrilin-2 gene (Matn2) is expressed in a great variety of
tissues, but at highly variable levels [3,5]. The gene is transcribed
and the protein is secreted by several established osteoblast,
fibroblast, myoblast and epithelial cell lines. Matn2 mRNA and
protein is also produced by hepatic oval cells, but not by
hepatocytes [9]. In an experimental model of rat liver regener-
ation, Matn2 was deposited in the basement membrane zone
around the tubules formed by oval cells, suggesting an important
role for the protein in liver regeneration [9].
Furthermore, Matn2 is expressed in certain tumors. Sporadic
pilocytic astrocytoma, a pediatric brain tumor, is characterized by
PLOS ONE | www.plosone.org 1 April 2014 | Volume 9 | Issue 4 | e93469
elevated MATN2 mRNA and protein level [10]. We also recently
reported increased MATN2 expression both at mRNA and protein
levels in human liver cirrhosis and liver cancer [11]. While in
normal human liver MATN2 is located in the walls of portal
vessels, in hepatocellular carcinoma (HCC) it is intensively
detected in the tumor vessels. However, it remains unknown
how MATN2 contributes to tumor formation.
Targeted disruption of Matn2 in transgenic mice did not cause
obvious phenotypic alterations [12]. Matn2-/- mice are viable,
fertile and histological analyses did not reveal any obvious
alterations in the architecture of mutant tissues at various
embryonic and postnatal stages. However, no information is
available about the consequences of Matn2 deficiency on tumor
formation. To address this question here we investigated the role
of Matn2 in vivo using an experimental mouse model of
hepatocarcinogenesis. In Matn2-deficient livers we could demon-
strate spontaneous appearance of tumorous foci, as well as
markedly increased tumor formation upon diethylnitrosamine
(DEN) treatment. Furthermore, we uncovered several alterations
in signaling pathways likely to be involved in the pathomechanism
of tumor formation.
Materials and Methods
1. Animals and treatment
Inactivation of Matn2 in embryonic stem cells and generation of
inbred (129/SV) mouse strains have been described elsewhere
[12]. Matn2+/2 heterozygotes were mated to generate Matn2+/+
(wild-type, WT) and Matn2-/- homozygotes for tumorigenesis.
Fifteen-day old male WT and Matn2-/- mice were injected
intraperitoneally with DEN at a dose of 15 mg/g body weight.
Each group, including WT and Matn2-/- untreated controls as well
as DEN-treated mice, consisted of $10 animals. Mice were
terminated 10 months after DEN exposure by cervical dislocation
in ether anesthesia. At termination, body weight and liver weight
of the animals were measured and the number of macroscopically
detectable tumors was counted.
All animal experiments were conducted according to the ethical
standards of the Animal Health Care and Control Institute
Csongra´d County, Hungary. The protocol was approved by the
Committee of the Animal Health Care and Control Institute
Csongra´d County, Hungary (permit No. XVI/03047-2/2008).
2. RNA extraction, reverse transcription and RT-PCR
RNA was isolated from frozen livers. After homogenization in
liquid nitrogen the total RNA was isolated using the RNeasy Mini
Kit (Qiagen, Hilden, Germany), according to the protocol
provided by the manufacturer. The yield and purity of the
isolated RNA was estimated by the ND-1000 spectrophotometer
(NanoDrop Technologies, Wilmington, Delaware, USA). The
integrity and size distribution of the total RNA was analyzed using
Experion Automated Electrophoresis Station (Bio-Rad, Hercules,
CA, USA).
cDNAs were generated from 1 mg of total RNA by M-MLV
Reverse Transcriptase kit (Invitrogen by Life Technologies,
Carlsbad, California, USA) following the instructions of the
supplier. Real-time PCR (RT-PCR) was performed by ABI Prism
7000 Sequence Detection System (Applied Biosystems by Life
Technologies, Welterstadt, Germany), using ABI Taqman Gene
Expression Assays for b-actin (assay ID: Mm00607939_s1), Matn2
(assay ID: Mm01166023_m1) according to the manufacturer’s
protocol, mouse b-actin was used as endogenous control. All
samples were run in duplicates in a 20 ml reaction volume with
50 ng of cDNA. Results were obtained as threshold cycle (CT)
values. Expression levels were calculated by using the 22DC T
method.
3. Phospho-MAPK and Phospho-RTK antibody arrays
For phosphoprotein antibody arrays and Western blot analysis
proteins were isolated from frozen liver tissues. After homogeni-
zation in liquid nitrogen 1 ml of lysis buffer (20 mM TRIS
pH 7.5, 2 mM EDTA, 150 mM NaCl, 1% Triton-X100, 0.5%
Protease Inhibitor Cocktail (Sigma, St. Louis, MO,USA)) was
added to the samples. After incubation for 30 min on ice, samples
were centrifuged at 13000 rpm for 20 min. Supernatants were
saved and protein concentrations were measured according to
Bradford et al [13].
The activities of phospho-mitogen-activated protein kinase
(phospho-MAPK) and phospho-receptor tyrosine kinase (phos-
pho-RTK) were assessed by their relative levels of phosphorylation
using the Proteome Profiler Array (R&D Systems, Minneapolis,
MN, USA) according to the manufacturer’s instructions. The same
liver protein samples were used for Western blot. Pooled samples
of three livers from the same experimental group were homog-
enized in lysis buffer (described above) and adjusted to 300 mg
protein/250 ml lysate. Signals were developed by incubating the
membrane in SuperSignal West Pico Chemiluminescent Substrate
Kit (Thermo Fisher Scientific Inc., Waltham, MA USA), and
visualized on a Kodak Image Station 4000MM Digital Imaging
System.
4. Western blot analysis
Thirty mg of total proteins were mixed with loading buffer
containing b-mercaptoethanol and were incubated at 95uC for
5 min. Pooled samples of three from the same experimental group
were loaded onto a 10% polyacrylamide gel and were run for
30 min at 200 V on a Mini Protean vertical electrophoresis
equipment (Bio-Rad, Hercules, CA, USA). Proteins were trans-
ferred to polyvinylidene fluoride (PVDF) membrane (Millipore,
Billerica, MA, USA) by blotting overnight at 100 mA. Ponceau
staining was applied to determine the efficiency of blotting.
Membranes were blocked with 3% (w/v) non-fat dry milk (Bio-
Rad) in TBS for 1 hour followed by incubation with the primary
antibodies (p53, b-Catenin, glycogen synthase kinase 3 beta (GSK-
3b), p-GSK-3a/b, p-c-Myc, extracellular signal-regulated kinases
1/2 (Erk1/2), p-Erk1/2, cyclin-dependent kinase inhibitor 1 (p21/
CIP1), phospho-retinoblastoma (p-Rb), diluted 1:500-1:1000) at
4uC for 16 hours. Beta-actin served as loading control. Mem-
branes were washed 5 times with TBS containing 0.5% (v/v)
Tween20, then were incubated with appropriate secondary
antibodies conjugated with HRP enzyme for 1 hour. Afterwards
membranes were washed as before and signals were visualized
with SuperSignal West Pico Chemiluminescent Substrate Kit
(Thermo Fisher Scientific Inc.). Band densities were determined by
Kodak Image Station 4000MM Digital Imaging System. Antibody
data are provided in Supporting Information (Table S1).
5. Histological and immunohistochemical analysis
Liver samples were either frozen for further processing or fixed
in 10% formaldehyde and embedded in paraffin for histological
analysis. Paraffin sections were dewaxed in xylene and stained with
hematoxylin and eosin (HE). Stained sections were used for
histological diagnosis.
Immunofluorescence staining was performed on methanol-
acetone-fixed 10-mm cryosections. Nonspecific binding was
blocked first with 10% (w/v) normal donkey or goat serum in
phosphate buffered saline (PBS) for 1 h. The specimens were
incubated at 4uC overnight with primary antibodies (Matn2,
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laminin, b-Catenin, GSK-3b, p-GSK-3a/b, p-c-Myc diluted
1:200-1:400). After washing in PBS, sections stained for b-Catenin,
GSK-3b, p-GSK-3a/b and p-c-Myc were incubated with Alexa
Fluor 555 donkey anti-rabbit IgG secondary antibody (Invitrogen
by Life Technologies) for 30 min at room temperature in a dark
chamber. Nuclei were stained with 1 mg/ml 49,6-diamidino-2-
phenylindole (DAPI) in PBS for 5 min. Sections stained for Matn2
and laminin were washed and incubated with a combination of
Cy3-conjugated donkey anti-goat IgG and Cy2-conjugated
donkey anti-rabbit IgG antibodies, respectively (Jackson Immu-
noResearch Laboratories Inc., West Grove, PA, USA). Pictures
were taken by Nikon Eclipse E600 microscope with the help of
Lucia Cytogenetics version 1.5.6 program or Bio-Rad MRC 1024
confocal laser microscope.
The antigen retrieval on the deparaffinized tissue sections was
performed by Target Retrieval Solution (Dako, Glostrup, Den-
mark) in a pressure cooker under maximal pressure for 3 minutes,
followed by proteinase K (0.5 mg/ml) digestion for 10 minutes. To
inhibit endogenous peroxidases, samples were treated with 10%
H2O2 in methanol for 30 minutes at room temperature. Normal
serum was applied to block any nonspecific binding, and the slides
were incubated with primary antibodies raised against specific
proteins (p53, p-Erk1/2, p21/CIP1, Ki-67, p-Rb diluted 1:75-
1:500) at 4uC overnight. Subsequently, the slides were incubated
for 30 minutes with biotinylated goat anti-rabbit IgG secondary
antibody at room temperature. A detailed list of the antibodies
used in this study is presented in Supporting Information (Table
S1). Signal amplification was made by avidin-biotin complex
(ABC) (Vector Laboratories, Burlingame, CA USA) in a dilution of
1:50 for 30 min at room temperature. The signal was detected
with 3,3-diaminobenzidine tetrahydrochloride (DAB) substrate
chromogen solution (Dako) followed by counterstaining with
hematoxylin. Pictures were taken by MRC-1024 confocal laser
scanning microscope (Hemel Hempstead, UK), Nikon Eclipse
E600 fluorescent microscope (Tokyo, Japan), and Olympus BX50
(Tokyo, Japan) microscope.
6. Determination of Ki-67 index
After immunostaining of Ki-67 in liver sections of 5-5 animals,
the number of immunopositive cells was counted in 10 fields of
each slide at a magnification of 2006by Olympus BX50 (Tokyo,
Japan) microscope.
7. Calculation of tumor volume
To determine the tumor volume of livers, HE stained sections
were scanned by Panoramic Scan (3D Histech Ltd., Budapest,
Hungary). The length and width of tumors in each section were
determined with the help of Panoramic viewer program (3D
Histech Ltd.) Tumor volume was calculated as V = (a2*b*p)/6
where ‘a’ refers to width (mm) and ‘b’ stands for length (mm).
8. Statistical analysis
All statistical analyses were made with Graphpad Prism 4.03
software (Graphpad Software Inc.). Data were tested for normal
distribution by D’Agostino & Pearson’s omnibus normality test.
Significance of changes in WT control vs. WT DEN, WT control
vs. Matn2-/- control, WT DEN vs. Matn2-/- DEN and Matn2-/-
control vs. Matn2-/- DEN were tested by non-parametric tests
(Mann-Whitney) and Students’ t-tests depending on the distribu-
tion of the data. The independent experimental sets were then
compared for reproducibility. Only reproducible significant
changes were considered as ’’significant’’. Significance was
declared at the standard p,0.05 level.
Figure 1. Immunolocalization of Matn2 in the liver of young mice (A). Matn2 immunostaining is most intense around the portal blood
vessels (arrowhead) on a frozen section of a 40-day old WT mouse liver. Matn2 partially colocalizes with laminin; however, in several structures Matn2
staining is more intense (arrowheads). There is no immunosignal in the matching area in the liver of a Matn2-/- mice. Bar, 0.1 mm. Representative
histological stain of WT control, WT DEN-treated, Matn2-/- control and Matn2-/- DEN-treated mouse livers (B). Scale bars represent
0.1 mm.
doi:10.1371/journal.pone.0093469.g001
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Results
1. Lack of Matn2 increases the proliferative capacity of
liver cells
In the livers of young WT mice, Matn2 protein was clearly
detected around the portal blood vessels, showing partial
colocalization with laminin. No reaction was detectable in the
livers of Matn2-/- mice, confirming the knockout phenotype of
these animals (Figure 1A).
Without any experimental challenge, neoplastic foci appeared
in livers of Matn2-/- mice at the age of 10 months as seen in HE
sections (Figure 1B). To confirm their proliferative capacity Ki-67
immunostaining was applied (Figure 2A), which showed a
scattered pattern of positive cells in Matn2-/- liver sections but
not in the WT livers. In knockout samples an average of 4.1 Ki-67
positive cells were counted per field compared to 0.7 in WT (p,
0.001) (Figure 2B).
Next, p21/CIP1, a potent CDK inhibitor, and retinoblastoma
(Rb) protein, two key regulatory molecule of the G1 cell cycle
checkpoint were examined in whole liver homogenates. Western
blot analysis revealed a ,50% decrease in p21/CIP1 protein
levels in Matn2-/- livers compared to WT samples (p,0.001)
(Figure 2C, 2D). In parallel, phosphorylation of Rb at T780 was
found to be significantly increased by 70% in Matn2-/- samples
(p,0.001) (Figure 2C, 2D). In a good agreement with Western
blot results, immunostaining of p21/CIP1 showed lower number
of hepatocytes with positive nuclear reaction in Matn2-/- animals
than in the WT (Figure 2A). Moreover, nuclei of Matn2-/- control
livers reacted with phospho-Rb antibody, whereas the reaction
was absent from WT livers (Figure 2A).
To specify the signal transduction pathways involved in the
activation of cell cycle, a phospho-MAPK array was applied
(Figure S1) and validated by Western blots. Erk1/2, a member of
the Ras/MAPK pathway, was spontaneously phosphorylated in
Matn2-/- control livers as revealed by Western blot (Figure 3A/1,
3B). Immunostaining localized these activated cells into the
hepatic foci (Figure 4).
Western blot indicated the outstanding role of GSK-3 proteins,
too, in the activation ofMatn2-/- hepatocytes. Both GSK-3 a and b
exhibited higher phosphorylation levels at the classical inhibitory
sites Ser9 and 21, respectively, in knockout livers compared to the
WT (Figure 3A/2, 3B). In the case of p-GSK-3b a highly
significant 9-fold elevation was observed, while the total amount of
the protein did not show any notable change. Immunostaining of
phospho-GSKs and total GSK-3b confirmed the results obtained
by Western blot (Figure 4, 3A/2, 3B).
The amount of b-catenin, one of the key signaling molecules in
the Wnt pathway, increased to 138% in untreated Matn2-/- mice
compared to WT (Figure 3A/1, 3B). In parallel, fluorescent
immunostaining revealed its translocation from the membrane to
the cytoplasm of hepatocytes (Figure 4).
Figure 2. Representative immunohistochemical stains of WT control, WT DEN-treated, Matn2-/- control and Matn2-/- DEN-treated
mouse livers (A). Scale bars represent 0.1 mm and 0.001 mm (insets) for paraffin-embedded samples. Changes in cell cycle regulation. Ki-67
proliferation index (B). In knockout samples an average of 4.1 Ki-67 positive cells were counted per field of view compared to 0.7 in WT (p,0.001) (B).
Results are expressed as mean 6 SD. Representative Western blots of cell cycle regulatory proteins (C) in WT control, WT DEN-treated,
Matn2-/- control andMatn2-/- DEN-treated mouse livers. Diagrams of band intensities expressed as values normalized to b-Actin loading control
(D). Data are expressed as mean 6 SD, n = 3.
doi:10.1371/journal.pone.0093469.g002
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As GSK-3a/b is able to phosphorylate and thus inactivate c-
Myc, this important proto-oncogene was also included in our
investigation [14]. Indeed, phosphorylation of c-Myc at Thr58
residue was markedly lower in untreated Matn2-/- livers than in the
corresponding WT ones (30% vs. 100%) (Figure 3A/1, 3B),
probably reflecting impaired GSK-3b activity.
In summary, in untreated Matn2-/- livers GSK-3a/b becomes
inactivated by phosphorylation and hence fails to phosphorylate c-
Myc and b-catenin, thereby rescuing them from degradation. As a
consequence, b-catenin translocates and accumulates in the
cytoplasm, and c-Myc is allowed to act as a transcription factor
in the nucleus (Figure 4).
To identify potential transmembrane receptors that may
transmit the altered signal from the extracellular matrix into the
cells, a phospho-RTK array was carried out. The amount of active
epidermal growth factor receptor (EGFR) was slightly higher in
Matn2-/- control livers than in WT samples (Figure 5A, 5B).
Differences between the Matn2-/- and WT control groups with
regard to signaling are summarized in Table 1.
2. Ablation of Matn2 results in enhanced tumor
formation in experimental hepatocarcinogenesis
To address the role of Matn2 in tumorgenesis, HCC in Matn2-/-
and WT mice was induced by administering a single dose of DEN.
DEN-exposed WT and Matn2-/- mice were compared to mock-
injected littermates 10 months after treatment. DEN treatment
induced macroscopic tumors in 78% of WT mice, whereas tumor
frequency was 100% in the liver of Matn2-/- animals. A higher
number of macroscopic tumors developed in Matn2-/- livers, with
an average number of 23 tumors/liver in contrast with 4 counted
in WT livers (p,0.01, Figure 6B). Moreover, not only the number
but also the size of tumors was significantly larger in the livers
lacking Matn2, (mean tumor volumes, 248 mm3 vs. 43 mm3, p,
0.01) (Figure 6A, 6C).
a. Events of hepatocarcinogenesis in the presence of
Matn2. In WT animals, DEN treatment initiated HCC
formation with molecular changes already known from earlier
studies of hepatocarcinogenesis. In DEN-provoked livers 15%
Figure 3. Representative Western blots of intracellular regulatory proteins in WT control, WT DEN-treated, Matn2-/- control and Matn2-/-
DEN-treated mouse livers (A/1, A/2). Results of densitometrical analysis of band intensities expressed as values normalized to b-Actin loading control
(B). Data are expressed as mean 6 SD, n = 3.
doi:10.1371/journal.pone.0093469.g003
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higher matrilin-2 mRNA level was detected than that of untreated
control livers (p,0.05) (Figure S2).
Whereas no immunopositivity for Ki-67 was detected in
untreated WT liver sections, the reaction in DEN-exposed WT
livers revealed a high number of immunopositive cells with an
average count of 49/field (p,0.001 vs. WT control) (see
Figure 2B). These cells were localized to the tumorous areas
reflecting high proliferative activity. A marked,1.5-fold induction
was detected in the levels of p21/CIP1(p,0.001), as well as a 2.3-
Figure 4. Representative immunofluorescence and immunohistochemical stains of WT control, WT DEN-treated, Matn2-/- control
and Matn2-/- DEN-treated mouse livers. Scale bars represent 0.1 mm and 0.001 mm (insets) for paraffin-embedded samples and 0.05 mm for
frozen tissue sections.
doi:10.1371/journal.pone.0093469.g004
Figure 5. Results of Phospho-RTK antibody array. Picture of RTK array membrane (A). Densitometry of phosphorylation signals in WT control
(dark gray bars) and WT DEN-treated (white bars) samples, compared to control (black bars) and Matn2-/- DEN-treated (light gray bars) samples (B).
Data are expressed as mean 6 SD, n= 3.
doi:10.1371/journal.pone.0093469.g005
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fold increase in the amount of phospho-Rb (T780) (p,0.001) in
WT DEN samples compared to WT control ones.
DEN treatment caused a ,1.5-fold elevation of total Erk1/2
proteins compared to the untreated WT animals. Moreover,
phosphorylation of these proteins was also significantly higher after
DEN treatment than in controls, as seen both by immunostaining
and Western blot (Figure 4, 3A/1, 3B).
The inactive phosphorylated forms of GSK-3a/b were
increased in tumor-bearing livers. Compared to the normal livers
a 60% elevation for a and 80% for b was measured by
densitometry of Western blots (Figure 3B). In parallel, total
GSK-3b showed a 2-fold increment in WT DEN samples
(Figure 3B). Immunohistochemical studies confirmed these obser-
vations, too (Figure 4).
Compared to WT controls, inhibition of GSK activity resulted
in 1.56 higher amount of b-catenin and 70% less c-Myc
phosphorylation in WT DEN liver homogenates, as revealed by
Western blots (Figure 3B). Immunostaining of b-catenin demon-
strated its translocation from the cell membrane and accumulation
Table 1. Differences between WT control and Matn2-/- control group compared to WT control.
Total protein Phosphorylation Immunostaining Localization
EGFR - q - -
Erk1/2 qqq qqq qq cytoplasm, nucleus
GSK-3a/b q qq q cytoplasm
b-Catenin q - q cytoplasm
c-Myc - Q (inactivating) - cytoplasm, nucleus
p21/CIP1 Q - Q nucleus
Ki-67 - - q nucleus
Rb - q qq nucleus
doi:10.1371/journal.pone.0093469.t001
Figure 6. Results of DEN treatment in WT and Matn2-/- animals. Representative pictures of the macroscopic appearance of WT and Matn2-/-
DEN-treated mouse livers. 10 months after DEN exposure the number and size of macroscopic tumors were greater in Matn2-/- than in WT livers (A).
The number of tumors/animal (B) and the tumor volume (C) were significantly higher in Matn2-/- mice compared to WT mice after DEN-treatment
(n = 9 for WT DEN, n = 13 for Matn2-/- DEN, **p,0.01).
doi:10.1371/journal.pone.0093469.g006
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in the cytoplasm. A loss of p-c-Myc was also evident by
immunohistochemistry (Figure 4).
By phospho-RTK array, significantly higher phospho-EGFR
levels were detected in the homogenates from DEN-treated WT
wild-type animals compared to control ones (Figure 5A, 5B). No
changes in macrophage stimulating protein receptor (MSPR) and
platelet-derived growth factor receptor (PDGFR) phosphorylation
were seen.
Differences between WT control and WT DEN groups are
summarized in Table 2.
b. The lack of Matn2 causes changes similar to DEN
treatment in the liver of WT animals. Table 1 shows
molecular differences between untreated WT and Matn2-/-
animals; Table 2 summarizes differences between untreated and
DEN-treated WT mice. Comparison of these two tables reveals
remarkable similarities. For EGFR, Erk1/2, GSKs, b-Catenin, p-
c-Myc, Ki-67, and p-Rb, the direction and magnitude of changes
are nearly identical between WT control vs. Matn2-/- control and
WT control vs. WT DEN groups. Our data indicate that Matn2-/-
hepatocytes harbor alterations that make them prone to malignant
transformation even without hepatocarcinogenic challenge; in-
deed, Matn2-/- mice developed spontaneous foci in the liver. Only
a single protein, p21/CIP1, behaved differently in these compar-
isons. p21/CIP1 was induced upon DEN treatment in WT livers;
however, the lack of Matn2 seemed to interfere with the induction
of p21/CIP1.
c. Alterations in the liver of Matn2-deficient mice after
HCC induction. As mentioned previously, Matn2-deficient
mice were more sensitive to DEN treatment, displaying higher
number of tumors with significantly larger volume in their livers
compared to the WT DEN group (see Figure 6A–C). We also
described that Matn2-/- livers had an activated, pro-proliferatory
phenotype without any experimental challenge.
When compared to Matn2-/- control, 24.4 times more Ki-67
immunopositive cells were counted in sections of matrilin-2
deficient livers after DEN treatment (Figure 2B). In parallel, a
1.6-fold increase in p21/CIP1 levels was detected inMatn2-/- DEN
homogenates relative to Matn2-/- controls (p,0.01) (Figure 3C,
3D). Among the intracellular signaling molecules, a 1.5-fold
elevation in p-Erk1/2 and a 65% decrease in p-c-Myc levels were
observed by Western blot, and confirmed by immunostaining
(Figure 4, 3A/1, 3B). Furthermore, slightly lower levels of b-
Catenin and p-GSKa/b were detected (Figure 4, 3A/1, 3A/2,
3B), and phospho-EGFR displayed a 1.9-fold increase (Figure 5A,
5B) in Matn2-/- DEN samples as compared to Matn2-/- controls.
These molecular changes are summarized in Table 3.
As seen in Table 3, DEN treatment did not lead to robust
molecular alterations inMatn2-/- livers. The elevation of Ki-67 was
the most prominent, as the tumors developed upon HCC
induction had a high rate of cell division. In conclusion, since
the lack of Matn2 had already driven hepatocytes into an activated
state, DEN treatment caused only modest intensification of pro-
proliferative signaling.
When comparing groups of WT and Matn2-/- mice both treated
with DEN, higher proliferation rate was seen in Matn2-/- DEN
livers, as the average Ki-67-positive cell count was 49 in WT and
100 in Matn2-/- livers after DEN exposure (Figure 2B). In parallel,
46% less p21/CIP1 protein was present in DEN-treated Matn2-/-
livers as compared to DEN-treated WT (p,0.001) (Figure 2C,
2D). With regard to intracellular signaling molecules, p-GSK-3a/
Table 2. Differences between WT control and WT DEN group compared to WT control.
Total protein Phosphorylation Immunostaining Localization
EGFR - qqq - -
Erk1/2 qq qqq qqq cytoplasm, nucleus
GSK-3a/b qq q q cytoplasm
b-Catenin q - q cytoplasm
c-Myc - QQ - cytoplasm, nucleus
p21/CIP1 qq - qq nucleus
Ki-67 - - qqq nucleus
Rb - q q nucleus
doi:10.1371/journal.pone.0093469.t002
Table 3. Differences between Matn2-/- control and Matn2-/- DEN group compared to Matn2-/- control.
Total protein Phosphorylation Immunostaining Localization
EGFR - q - -
Erk1/2 q q q= cytoplasm, nucleus
GSK-3a/b q Q =Q cytoplasm
b-Catenin Q - q cytoplasm
c-Myc - Q - cytoplasm, nucleus
p21/CIP1 q - q nucleus
Ki-67 - - qqq nucleus
Rb - =q = nucleus
doi:10.1371/journal.pone.0093469.t003
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b exhibited 2.4- vs. 3.8-fold increase, respectively, in Matn2-/- vs.
WT upon DEN treatment (Figure 3A/2, 3B) and, accordingly, in
Matn2-/- DEN the levels of p-c-Myc were only 37% of those
measured in WT DEN (Figure 3A/1, 3B). Conversely, the active
phospho-form of Erk2 was markedly, by 20%, higher in Matn2-/-
DEN relative to WT DEN (Figure 3A/1, 3B). However, the
amount of active p-EGFR in Matn2-/- DEN was as low as 45% of
that measured in WT DEN (Figure 5A, 5B).
Differences between WT DEN and Matn2-/- DEN groups are
summarized in Table 4. This comparison suggests that the
underlying mechanism behind the higher number and volume of
tumors experienced in DEN-treated Matn2-/- livers may involve
enhanced GSK-3b inactivation and hindered p21/CIP1 induc-
tion, leading to elevated proliferation rate indicated by Ki-67.
Discussion
Despite the relatively detailed data available on matrilin-2
structure and tissue expression, its function has not yet been
elucidated [3,5,15,16]. Matn2 is an ECM protein, which was
found to be expressed in the liver progenitor oval cells [9]. Only
one report implicated MATN2 in human HCC, but without
analysis of Matn2-related signaling [11]. In the current study a
functional analysis was applied using the well-established DEN-
induced HCC model [12]. The induction of macroscopic tumors
required 10 months in both WT and Matn2-/- mice. In matrilin-2-
deficient animals, however, significantly more, and more volumi-
nous tumor foci have developed. Furthermore, quite surprisingly,
sporadic microscopic tumor foci spontaneously appeared in the
liver ofMatn2-/- mice without DEN treatment at age of 10 months.
This result evidenced that the lack of Matn2 triggers an activated
state in the liver, making it prone to tumor development. Our
observations suggest a protective role for Matn2 against liver
carcinogenesis. To explore the underlying mechanisms, activation
of key signal transduction proteins in Matn2-/- animals has been
investigated in more detail.
The most conspicuous finding in Matn2-/- livers was increased
phosphorylation of Erk1/2. Activation of the MAPK pathway
most likely was a critical event related to the absence of Matn2
from the ECM, and this might be one of the key alterations
responsible for the increased susceptibility of hepatocytes to cancer
development. In addition, inactivation of GSK-3a/b proteins was
revealed by Western blot. This implies that beside Erk1/2
activation the signal generated in the absence of Matn2 utilizes
the Wnt pathway and inactivates GSK-3b and -3a by phosphor-
ylation at Ser9 and Ser21 residues. Although it is mostly protein
kinase B (Akt protein) that inactivates GSK-3b [17], and phospho-
MAPK array in our study indicated slightly increased phosphor-
ylation of p38, pan Akt, and Akt3, we could not confirm this result
on Western blot. On the other hand Ding and coworkers
published that Erk1/2 is also capable of priming GSK-3b for
inactivation by phosphorylating it at the T43 residue [18].
Conversely, it has also been reported that inhibition of GSK-3b
significantly induces phosphorylation of Erk1/2 through PKCd
activation [19].
In accordance with the inactivation of GSK-3b we were able to
demonstrate an increase in b-catenin protein levels, and a decrease
in the inactivating phosphorylation of c-Myc at the Thr58 residue.
Suspension of GSK-3b-mediated inhibitory effects brings hepato-
cytes into a proliferative state [20]. Indeed, accelerated cell cycling
in untreated Matn2-/- mice was confirmed by immunostaining for
Ki-67. Whereas b-catenin in the WT control livers was confined to
the cell membrane, the protein accumulated in the cytoplasm in
Matn2-/-, but no nuclear localization was ascertained. Currently
we cannot explain why b-catenin failed to translocate to the
nucleus, since its localization is thought to be solely determined by
Figure 7. Schematic illustration of the predicted signaling
mechanisms in Matn2-/- mice. Molecules studied in this work are
labeled by asterisks. Empty boxes show upregulation and/or activation;
gray boxes indicate downregulation and/or inactivation of the protein.
doi:10.1371/journal.pone.0093469.g007
Table 4. Differences between WT DEN and Matn2-/- DEN group compared to WT DEN.
Total protein Phosphorylation Immunostaining Localization
EGFR - Q - -
Erk1/2 Q q = cytoplasm, nucleus
GSK-3a/b Q qq Q cytoplasm
b-Catenin Q - q cytoplasm
c-Myc - Q - cytoplasm, nucleus
p21/CIP1 QQ - Q nucleus
Ki-67 - - qq nucleus
Rb - Q= q nucleus
doi:10.1371/journal.pone.0093469.t004
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the availability and phosphorylation of its binding partners. This
aspect of the mechanism needs further investigation [21].
Beside the b-catenin-related mechanism, Jin et al. reported that
GSK-3b has a critical role in the phosphorylation-mediated
inactivation of the Cyclin-dependent kinase 4/CyclinD3 complex
(Cdk4/CyclinD3). This offers another approach how the inacti-
vation of GSK-3b may result in increased proliferation [22].
Our results regarding p21/CIP1 fit very well into the model
outlined. p21/CIP1 levels increased upon DEN-treatment in WT
mouse liver, which is in line with the available reports [23]. In
contrast, lack of Matn2 resulted in a decrease of p21/CIP1 levels
in the liver, and DEN induction failed to reverse this tendency.
This implies that a Matn2-facilitated signaling may be essential for
the upregulation of p21/CIP1 in DEN-induced liver carcinogen-
esis. Our results demonstrating the inactivation of GSK-3b and a
consequent decrease in the phosphorylation of c-Myc can explain
this finding, as c-Myc is known to induce AP4 which serves as an
inhibitory transcription factor of p21/CIP1 [24].
Erk1/2 activation in the context of DEN treatment has been
reported to increase the expression and stability of p21/CIP1 [25].
This stabilized p21/CIP1 might be at least partly functional,
resulting in relatively attenuated tumor formation in the DEN-
treated WT mouse liver. Indeed, we could observe p21/CIP1
upregulation in the liver of DEN-treated WT mice at the protein
level. Such upregulation upon DEN treatment was also seen in the
Matn2-/- animals; however, this induction failed to compensate for
the initially lower p21/CIP1 levels in Matn2-/-. Hence, the
absolute amount of p21/CIP1 remained lower in the DEN-
treatedMatn2-/- mice, too. InMatn2-/- animals, activation of GSK-
3b/c-Myc/p21/CIP1 axis may result in transcriptional inhibition
of p21/CIP1 synthesis. The above-mentioned Erk1/2-mediated
stabilization of p21/CIP1 is also likely to be Matn2-dependent
[25]. Other mechanisms probably involved in p21/CIP1 protein
inactivation include calreticulin-induced inhibition of translation
[26], miR-106-induced inactivation, or degradation by the
proteasomal system [27].
Increased phosphorylation of Rb protein at Ser780 in Matn2-/-
indicates that, as a consequence to p21/CIP1 downregulation, Rb
becomes inactivated by a Cdk4/CyclinD3-mediated process [22].
In addition, Erk1/2 has been reported to associate with the Cdk4/
CyclinD1 complex and facilitate its function [28]. This facilitation
may also lead to increased p-Rb phosphorylation in the liver of
Matn2-/- mice, since the ablation of Matn2 was shown to be
associated with elevated Erk1/2 activity.
To find the link between altered ECM composition and
modified signaling, tyrosine kinase receptor phosphorylation was
assessed. This revealed increased phosphorylation of EGFR only.
Considering that Matn2 contains several EGF-like domains it can
be hypothesized that Matn2 as a decoy molecule may interfere
with the binding of the real EGF ligand to its receptor. This could
imply that the lack of Matn2 increases the binding capacity of
EGFR to its real ligand, resulting in increased activation.
However, this hypothesis requires further studies to prove. Also,
despite our efforts, integrin receptors possibly involved in
mediating the effects of Matn2 could not so far be identified.
Conclusion
This study provides evidence that Matn2 functions as a tumor
suppressor in hepatocarcinogenesis. Matn2-/- animals showed
increased susceptibility to cancer induction, and spontaneously
developed atypical microscopic foci in the liver. Ablation of Matn2
is thought to contribute to hepatocarcinogenesis through 1)
activation of the MAPK signaling pathway; 2) inactivation of
GSK-3b with consequent increase in the amount of b-catenin and
activation of c-Myc; and 3) lowered levels of p21/CIP1 and
consequent Rb phosphorylation by Cdk4/CyclinD complexes
(Figure 7).
Supporting Information
Figure S1 Phospho-MAPK antibody array to assess the
activity of downstream signal transduction pathways.
Densitometry of phosphorylation signals in WT control (dark grey
bars) and WT DEN-treated (white bars), compared to control
(black bars) and Matn2-/- DEN-treated samples (light grey bars).
(TIF)
Figure S2 Matn2 mRNA expression in wild type control
and DEN-exposed livers detected by real-time RT-PCR.
As seen, 1.15-times more Matn2 mRNA was detected in tumorous
samples (WT DEN) compared to control ones (WT control). Data
are expressed as mean 6 SD, n= 10; *p,0.05.
(TIF)
Table S1 Antibodies used in the present study.
(DOC)
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